Please assess the completion status of the following clinical trial:

Trial Title: An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic creatinine clearance \</= 40cc/h~* Pre-operative cardiac surgery~Exclusion Criteria:~* Pre-operative ongoing dialysis~* Nausea and vomiting~* Uncontrolled glaucoma~* Allergy to metabisulfite~* Enrollment in another clinical study within 30 days~* Pregnancy~* Acute renal failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- NAC (Type: EXPERIMENTAL): N-acetylcysteine started day prior to surgery, continued through night of surgery
- fenoldopam (Type: EXPERIMENTAL): fenoldopam started at surgery continued for 24 hours
- NAC and fenoldopam (Type: EXPERIMENTAL): Both N-acetylcysteine and fenoldopam as above
- Control (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).